July 2016
Corporate HQ
Montreal, Canada

Caprion was transformed from a local Canadian leader in high growth sub-sector into a full service global CRO in immunology and biologics.

Specialised laboratory service business serving Pharma and Biotech companies in discovery, pre-clinical and clinical development R&D.

Value Creation Summary

Enablement & Alignment

Created a global leader in proteomics and immune oncology services, partnering with some of the largest pharma and most prominent biotechs in the industry.

High science, quality-led approach with a specialized global team supporting customers’ proteomics and immune oncology research and development needs.

Capability & Capacity

Implemented a new Lab Information Management System to better track workflow and profitability, allowing management to enhance KPIs and deliver on the very strong bookings growth.

Added significant resource to the business development function and restructured the sales force to focus on key account targeting, territory mapping and an integrated go-to market strategy.

Upgraded the finance and reporting function to improve on working capital and institutionalise management processes and systems.

Changed the revenue recognition to reflect increased project work and improve cashflow generation profile of the business

Building Strategic Footprints

Within a three-year hold period GHO completed three bolt-on acquisitions for Caprion, taking the business into five new geographies, adding numerous high-tech service offerings and delivering significant upgrades to the operational and service infrastructure of the business as well as tripling its number of employees

A full service global CRO with footprint on both sides of the Atlantic and a foothold in Asian markets

Expanding footprint and service offering through the acquisitions of ImmuneHealth, Primity Biosciences and Serametrix Corporation